DSG WINS SCDM’S DATA DRIVEN INNOVATION AWARD FOR CLINICAL DATA QUALITY CONTROL IMPLEMENTATION AT HUMAN GENOME SCIENCES
—DSG wins coveted award for second year in a row—
MALVERN, Pa., Jan. 12, 2009—DSG. Inc., an industry leader in clinical trial data collection and management, today announced that its collaborative work with Human Genome Sciences (HGS) was selected as the second place winner in the 2008 Society For Clinical Data Management (SCDM) Data Driven Innovation Award competition.
In its second year, the Data Driven Innovation Award recognizes and honors excellence in the advancement of clinical data management and celebrates innovation in vendor/sponsor relationships. Three judges selected from the SCDM Certified Clinical Data Managers agreed to honor the partnership between HGS and DSG for creating an interactive and centralized Clinical Data Quality Control (CDQC) checklist that combines both system data and user enterable data to assess the status of "cleanliness" for a given project.
The CDQC checklist provides HGS data managers with easy access to the real-time status of studies including readiness for database lock, overall progress, backlogged tasks and clean status on a by-subject level. This solution also provides metrics on data management and monitoring activities for each study that further enabled HGS to improve overall data management operations, saving both time and money. DSG’s solution enabled generation of ad-hoc reports which could be used by monitors to prepare for site visits. HGS’ data management group is now able to standardize relevant metrics and tracking tools across therapeutic area.
“Working with a trusted partner like DSG is helping improve the overall data management workflow through any clinical trial,” said Michael Goedde, Director of Clinical Data Management, HGS. “This award is testament to the collaborative and innovative nature of both organizations.”
Typically, the data manager cannot determine if study data is ready for lock without making inquiries into a number of different systems (e.g., CROs, central labs, interactive voice response) or functional areas (e.g., coding, clinical/safety review, serious adverse effect reconciliation). DSG’s solution automates this process and replaces the need for multiple inquiries and data management systems.
“We are honored to receive the Data Driven Innovation Award for the second year in a row,” said Tony Varano, chief executive officer of DSG. “This award provides further confirmation that we are developing highly successful and innovative solutions that improve trial efficiencies, accuracy and ultimately patient safety. DSG’s solutions have changed the way our customers collect, manage and integrate clinical trial data.”
"We were extremely pleased at the quality of the applicants for this award and look forward to continuing to recognize these types of partnerships at our 2009 meeting," said Ralph Russo (Assistant Director, Global Clinical Data Management, Schering-Plough Research Institute), SCDM Fall Conference Co-Chair.
About SCDM
The Society for Clinical Data Management (SCDM) is a not-for-profit organization dedicated to the professional development of the discipline of clinical data management. Founded in 1994, SCDM is the premier professional clinical data management organization with over 2,000 domestic and international members.
About Human Genome Sciences
Human Genome Sciences, headquartered in Rockville, Md., is a commercially focused biopharmaceutical company with a broad pipeline of novel drugs that includes three promising products in late-stage development, moving toward commercialization: Albuferon® in Phase 3 trials for hepatitis C and LymphoStat-B® in Phase 3 trials for systemic lupus and ABthrax™ in late-stage development for inhalation anthrax. For more information please visit www.hgsi.com
About DSG
DSG, Inc. supports clinical trial data collection and management with innovative technology solutions including Electronic Data Capture with specialized Clinical Data Management services, Electronic Patient Diaries, Clinical Trial Management Systems and digital on-demand Case Report Form publishing management software. DSG’s products allow user-friendly, accurate and efficient data capture at any investigator site regardless of the technological infrastructure. DSG has successfully supported over 500 clinical trials for more than 300 companies at over 18,000 sites in over 68 countries. Founded in 1992, DSG is a global company headquartered in Malvern, Pa., with additional offices in the U.S., Japan and India. For more information, please visit www.dsg-us.com
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.